BioSpace News Archive

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, provides further details on previously announced results of Thykamine™ Phase 2 clinical trial for the treatment of mild-to-moderate atopic dermatitis (AD).

Doximity, the leading digital platform for medical professionals, announced today the appointment of Regina Benjamin, MD, MBA, to its Board of Directors.

Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced results for the quarter ended December 31, 2020 and fiscal year 2020.

Keystone Heart, Ltd., a medical device innovator driven to redefine the standard of structural heart care, today announced an exclusive distribution agreement with InterValve Medical Inc. to sell and market their portfolio of balloon aortic valvuloplasty products, in the United States.

Today, the Biden administration announced a new partnership with dialysis providers to provide COVID-19 vaccinations to people receiving dialysis and health care personnel in outpatient dialysis centers.

This new antigen rapid test kit was approved by Health Canada on March 19th.

$3 Million in Prize Money Inspires the World’s Leading Food Allergy Researchers to Put an End to the Oral Food Challenge

Sequana Medical NV announces, in accordance with Article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, that two of the three convertible loans that were entered into with the Company have been converted for an aggregate amount of EUR 618,916.67 into an aggregate of 97,084 new shares in accordance with the terms of the convertible loans.

Nuclein, LLC has closed a $14 million Series B funding round. The financing helps Nuclein, a medical device company, to commercialize its novel, hand-held PCR platform designed as a disposable, all-in-one, self-test for infectious disease diagnosis.

The Midwest Bioprocessing Center (MBC), a leading producer of bio-based chemicals for human health and nutrition, announced today that it has acquired the technology, product line and production assets of iActive™ Naturals from the Biotechnology Research and Development Corporation (BRDC).